| Literature DB >> 14565909 |
Alexandros L Georgiadis1, José I Suarez.
Abstract
Raised intracranial pressure (ICP) is a major contributor to the mortality of many conditions encountered in a neurologic intensive care unit. Achieving a sustained reduction in ICP in patients with intracranial hypertension remains a challenge. Treatment with hyperosmolar agents is one of the few options that are available, and mannitol is currently the most commonly used agent. However, hypertonic saline solutions have recently emerged as a potentially safer and more efficacious alternative to mannitol.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14565909 DOI: 10.1007/s11910-003-0058-1
Source DB: PubMed Journal: Curr Neurol Neurosci Rep ISSN: 1528-4042 Impact factor: 5.081